Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Muscarinic acetylcholine receptor | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | n acetylated alpha linked acidic dipeptidase 2 | 0.0752 | 0.9739 | 0.5 |
Mycobacterium ulcerans | lipoprotein aminopeptidase LpqL | 0.0068 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable lipoprotein aminopeptidase LpqL | 0.0068 | 0 | 0.5 |
Schistosoma mansoni | NAALADASE L peptidase (M28 family) | 0.0493 | 0.6046 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0702 | 0.9025 | 0.7359 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 34 nM | In vitro binding affinity against Muscarinic receptor in rat cerebral cortex using [3H]- oxotremorine-M (OXO-M) using as a radioligand; Value ranges from 23-58 | ChEMBL. | No reference |
IC50 (binding) | = 34 nM | In vitro affinity evaluated using [3H]- oxotremorine as radioligand in rat cerebral cortex for muscarinic acetylcholine receptor | ChEMBL. | 9435896 |
IC50 (binding) | = 34 nM | In vitro inhibition of oxotremorine-M (OXO-M) binding to muscarinic receptors of rat cerebral cortex | ChEMBL. | No reference |
IC50 (binding) | = 34 nM | In vitro binding affinity against Muscarinic receptor in rat cerebral cortex using [3H]- oxotremorine-M (OXO-M) using as a radioligand; Value ranges from 23-58 | ChEMBL. | No reference |
IC50 (binding) | = 34 nM | In vitro affinity evaluated using [3H]- oxotremorine as radioligand in rat cerebral cortex for muscarinic acetylcholine receptor | ChEMBL. | 9435896 |
IC50 (binding) | = 34 nM | In vitro inhibition of oxotremorine-M (OXO-M) binding to muscarinic receptors of rat cerebral cortex | ChEMBL. | No reference |
IC50 (binding) | = 2000 nM | In vitro inhibition of [3H]-quinuclidinyl benzilate (QNB) binding to muscarinic receptors of rat cerebral cortex | ChEMBL. | No reference |
IC50 (binding) | = 2000 nM | In vitro inhibition of [3H]-quinuclidinyl benzilate (QNB) binding to muscarinic receptors of rat cerebral cortex | ChEMBL. | No reference |
IC50 (binding) | = 2200 nM | In vitro binding affinity against Muscarinic receptor in rat cerebral cortex using [3H]- quinuclidinyl benzilate (QNB)using as a radioligand; Value ranges from 2100-2300 | ChEMBL. | No reference |
IC50 (binding) | = 2200 nM | In vitro affinity evaluated using [3H]- quinuclidinyl benzilate as radioligand in rat cerebral cortex for muscarinic acetylcholine receptor | ChEMBL. | 9435896 |
IC50 (binding) | = 2200 nM | In vitro binding affinity against Muscarinic receptor in rat cerebral cortex using [3H]- quinuclidinyl benzilate (QNB)using as a radioligand; Value ranges from 2100-2300 | ChEMBL. | No reference |
IC50 (binding) | = 2200 nM | In vitro affinity evaluated using [3H]- quinuclidinyl benzilate as radioligand in rat cerebral cortex for muscarinic acetylcholine receptor | ChEMBL. | 9435896 |
Ratio (binding) | = 65 | Relative affinities compared to oxotremorine-M (OXO-M) and [3H]-quinuclidinyl benzilate (QNB) for muscarinic receptors | ChEMBL. | No reference |
Ratio (binding) | = 65 | Ratio of IC50 QNB to that of OXO-M was determined | ChEMBL. | 9435896 |
Ratio (binding) | = 65 | Selectivity is the ratio of inhibitory activities against muscarinic receptors, determined using radioligand [3H]-OXO-M and 3[H}-QND | ChEMBL. | No reference |
Ratio (binding) | = 65 | Selectivity is the ratio of inhibitory activities against muscarinic receptors, determined using radioligand [3H]-OXO-M and 3[H}-QND | ChEMBL. | No reference |
Ratio (binding) | = 65 | Ratio of IC50 QNB to that of OXO-M was determined | ChEMBL. | 9435896 |
Ratio (binding) | = 65 | Relative affinities compared to oxotremorine-M (OXO-M) and [3H]-quinuclidinyl benzilate (QNB) for muscarinic receptors | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.